Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Preclinical characterization of SLV-313, a novel D2 receptor antagonist/5-HT1A receptor agonist

Jan. 29, 2007

Barrow receives grant to support neurofibromatosis research

Jan. 26, 2007

New trial evaluates oral cladribine with Rebif for MS

Jan. 26, 2007

Intranasal insulin improves memory

Jan. 26, 2007

Preclinical characterization of SSR-180711, a novel selective alpha7 nAChRr partial agonist

Jan. 26, 2007

NNZ-2566 is safe in phase I study

Jan. 26, 2007

Transtec provides reliable analgesia in cancer pain patients

Jan. 26, 2007

Approvable letter for Pristiq for major depressive disorder

Jan. 25, 2007

University of Illinois researchers funded to develop new bipolar disorder drug

Jan. 25, 2007

Affectis inlicenses cimicoxib for CNS disorders

Jan. 25, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...